AI assistant
MORGAN STANLEY — Capital/Financing Update 2012
Oct 25, 2012
29766_rns_2012-10-25_c22392bb-a7ae-4af5-be3b-def6610ec91d.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
October 2012 Pricing Sheet dated October 23, 2012 relating to Preliminary Terms No. 383 dated October 15, 2012 Registration Statement No. 333-178081 Filed pursuant to Rule 433
STRUCTURED INVESTMENTS
Opportunities in International Equities
Buffered PLUS Based on the iShares ® MSCI EAFE Index Fund due October 27, 2014
Buffered Performance Leveraged Upside Securities SM
| PRICING TERMS – OCTOBER 23, 2012 — Issuer: | Morgan Stanley | ||
|---|---|---|---|
| Maturity date: | October 27, 2014 | ||
| Underlying shares: | Shares of the iShares ® MSCI EAFE Index Fund | ||
| Aggregate principal amount: | $2,230,000 | ||
| Payment at maturity per Buffered PLUS: | § If the final share price is greater than the initial share price: $10 + leveraged upside payment In no event will the payment at maturity exceed the maximum payment at maturity. | ||
| § If the final share price is less than or equal to the initial share price but has decreased from the initial share price by an amount less than or equal to the buffer amount of 10%: $10 | |||
| § If the final share price is less than the initial share price and has decreased from the initial share price by an amount greater than the buffer amount of 10%: | |||
| ($10 x share performance factor) + $1 | |||
| This amount will be less than the stated principal amount of $10. However, under no circumstances will the payment at maturity be less than $1 per Buffered PLUS. | |||
| Share percent increase: | (final share price – initial share price) / initial share price | ||
| Share performance factor: | final share price / initial share price | ||
| Leveraged upside payment: | $10 x leverage factor x share percent increase | ||
| Initial share price: | $53.35, which is the closing price of one underlying share on the pricing date | ||
| Final share price: | The closing price of one underlying share on the valuation date times the adjustment factor on such date | ||
| Adjustment factor: | 1.0, subject to adjustment in the event of certain events affecting the underlying shares | ||
| Valuation date: | October 22, 2014, subject to postponement for non-trading days and certain market disruption events | ||
| Leverage factor: | 200% | ||
| Buffer amount: | 10% | ||
| Maximum payment at maturity: | $12.60 per Buffered PLUS (126% of the stated principal amount) | ||
| Minimum payment at maturity: | $1 per Buffered PLUS (10% of the stated principal amount) | ||
| Interest: | None | ||
| Stated principal amount: | $10 per Buffered PLUS | ||
| Issue price: | $10 per Buffered PLUS | ||
| Pricing date: | October 23, 2012 | ||
| Original issue date: | October 26, 2012 (3 business days after the pricing date) | ||
| CUSIP: | 61755S826 | ||
| ISIN: | US61755S8263 | ||
| Listing: | The Buffered PLUS will not be listed on any securities exchange. | ||
| Agent: | Morgan Stanley & Co. LLC (“MS & Co.”), a wholly-owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest” in the accompanying preliminary terms. | ||
| Commissions and issue price: | Price to public | Agent’s commissions (1) | Proceeds to issuer |
| Per Buffered PLUS | $10 | $0.225 | $9.775 |
| Total | $2,230,000 | $50,175 | $2,179,825 |
(1) Selected dealers, including Morgan Stanley Smith Barney LLC (an affiliate of the agent), and their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $0.225 for each Buffered PLUS they sell. For additional information, see “Supplemental information regarding plan of distribution; conflicts of interest” in the accompanying preliminary terms and “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement for PLUS.
The Buffered PLUS are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.
You should read this document together with the preliminary terms describing the offering and the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below.
EFPlaceholder Preliminary Terms No. 383 dated October 15, 2012
EFPlaceholder Product Supplement for PLUS dated August 17, 2012
EFPlaceholder Index Supplement dated November 21, 2011
EFPlaceholder Prospectus dated November 21, 2011
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.